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Abstract
Background: Prognostic factors for the combination of long-term survival and health-related quality of life (HRQoL)
after intensive care unit (ICU) stay have not yet been studied. Our aim was to assess whether early acute kidney
injury (eAKI), AKI occurring on the first day of ICU admission, is an independent predictor of this combined one-year
outcome.
Methods: We included all patients admitted to the mixed ICU of the University Medical Centre Utrecht between
July 2009 and April 2013, excluding patients with chronic dialysis, cardiac surgery, and length of stay shorter than
24 hours. eAKI was defined using the risk, injury, failure, loss, end-stage renal failure (RIFLE) classification, using a
newly developed algorithm to classify AKI based on routinely collected patient data. In one-year survivors, HRQoL
was measured using the EuroQoL 5D-3L™ (EQ-5D) questionnaire. The primary outcome measure was “poor outcome”,
defined as an EQ-5D index score <0.4 or death after one year follow up. A multivariable Poisson regression model was
performed to adjust for age, comorbidities, admission type and severity of disease factors.
Results: We enrolled 2,420 patients, of whom 871 (36.0 %) died within one year. An additional 286 of 1549 one-year
survivors (11.8 %) experienced low HRQoL. The respective incidence of the RIFLE classes, risk, injury and failure, were
456 (18.8 %), 253 (10.5 %) and 123 (5.1 %). After adjustment for other covariates, the RIFLE classes, injury and failure,
were independently associated with poor outcome (adjusted relative risk 1.14, 95 % CI 1.01, 1.29; p = 0.03, and 1.
25, 95 % CI 1.01, 1.55; p = 0.04), when compared to no eAKI patients . The constituents of this composite
outcome were also analysed separately. In a Cox regression model the RIFLE classes, injury and failure, were
significantly associated with mortality (adjusted hazard ratio 1.35, 95 % CI 1.11, 1.65; p <0.01, and 1.78, 95 % CI 1.38, 2.
30; p <0.01). In one-year survivors specifically, none of the RIFLE classes were significantly associated with low HRQoL.
Conclusions: ICU patients with moderate or severe AKI during the first 24 hours have a higher probability of mortality
or low HRQoL (combined poor outcome), one year after ICU admission. Together with other available early prognostic
factors, information on early acute kidney injury could improve informed decision-making on the continuation or
withdrawal of treatment in ICU patients.
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Background
Early during ICU admission clinicians often find it difficult
to predict the long-term outcome of critically ill patients
[1]. Even during the course of an intensive care unit (ICU)
admission the prognosis may remain unclear. In order to
support decision-making on the continuation or with-
drawal of ICU treatment, identifying valid clinical predic-
tors early during ICU admission is particularly relevant [2].
The first day of ICU admission is critical for prognosis.
Its clinical relevance is made clear by the high prognos-
tic value of disease severity scores based on the first day
of ICU admission. A multitude of physiologic variables
are included in models such as the Acute Physiology and
Chronic Health Evaluation (APACHE) and Simplified
Acute Physiology Score (SAPS) [3, 4]. However, only the
presence of specific ICU complications such as acute kid-
ney injury (AKI) is taken into account. Worldwide estab-
lished and detailed classification systems for complications
identifying different levels of severity, were not used. A
considerable number of critically ill patients develop AKI
during their ICU stay [5]. Over twenty percent of all gen-
eral ICU patients do so within 24 hours of ICU admission
[6]. Moreover, when AKI does accompany critical illness,
it is a risk factor for increased mortality, up until one year
after ICU admission [5–14]. Early AKI (eAKI) could
be an especially prevalent warning sign of poor long-
term outcomes. If so, it could be used as a building
block for personalized prognoses.
Multiple studies have investigated predictors and
models for the short-term prognosis of the critically ill.
As a consequence, scoring systems such as APACHE IV
and SAPS 3 have been developed for risk stratification
[3, 4]. These studies focussed on associating predictors
and models with hospital mortality. To facilitate decision-
making on continuing or withdrawing treatment in the
ICU, however, patients and their relatives usually want to
be informed about the chances of survival beyond hospital
discharge. Often, they want to take the expected quality of
life into account. Health-related quality of life (HRQoL)
has only been studied scarcely as the outcome in prog-
nostic factor studies [15–17]. Especially in the general ICU
population studies the investigation of predictors of
HRQoL is rare. Furthermore, prognostic factors of a com-
bination of survival and HRQoL have not yet been studied.
Therefore, the aim of this study was to investigate
whether the occurrence and severity of eAKI, which is
defined as AKI occurring during the first 24 hours of ad-
mission, in a mixed ICU population is independently as-
sociated with one-year mortality and HRQoL.
Methods
Study design, setting and participants
All patients admitted consecutively to the mixed ICU of
the University Medical Center Utrecht from July 2009 to
April 2013, without chronic dialysis prior to ICU admis-
sion, were eligible for inclusion. In patients with multiple
ICU admissions within this period, only the first ICU
admission was used in the analyses. Patients under 16 years
of age and those with a length of stay shorter than 24 hours
were excluded. Patients admitted to the ICU after cardiac
surgery were excluded because of the low incidence of
AKI [18], and low risk of poor outcome in these patients
in general [16]. The Institutional Review Board (IRB) of
the University Medical Center Utrecht approved the study
protocol and waived the need for informed consent when
working with anonymised patient and follow-up data
(UMC Utrecht IRB protocol number 10/006).
Data collection and follow up
The following data were collected: serum creatinine
levels, urine output per hour within the first 24 hours,
age, sex, pre-ICU hospital length of stay, admission type,
Charlson Comorbidity Index [19, 20], the need for
mechanical ventilation, confirmed infection and the
acute physiology score (APS, as part of the APACHE II
score) within the first 24 hours of admission. These vari-
ables were prospectively collected according to strict
definitions, as part of a national registry used for bench-
marking [7]. Data on the Charlson Comorbidity Index
were obtained from the electronic patient files, as was
described previously [21].
After hospital discharge, patient survival was tracked
using the municipal registry. All patients surviving one
year after ICU admission were sent the EuroQoL 5D-
3L™ (EQ-5D) HRQoL questionnaire [22]. If this ques-
tionnaire had not been returned within six weeks, the
questionnaire was resent and patients were reminded by
telephone to return the questionnaire. More details on
the definitions of the Charlson Comorbidity Index and
the EQ-5D can be found in Additional file 1.
Early AKI
The presence of eAKI was determined according to the
risk, injury, failure, loss, end-stage renal failure (RIFLE)
classification [5]. This classification is based on measure-
ments of serum creatinine, urine output per hour and the
use of renal replacement therapy. A risk; injury; failure
(RIF) classification of renal impairment (analogous with
the RIFLE system) was used. An algorithm was developed
to determine the presence of these acute RIFLE classes
within the first 24 hours of ICU stay, based on routinely
collected data. RIFLE based on serum creatinine was
scored by calculating the factor of change in serum cre-
atinine from baseline. The baseline was defined as the
lowest serum creatinine value in the 6 months prior to
ICU admission, when available in the hospital labora-
tory registry. If this was unavailable, the lowest serum
creatinine during the first day of admission was used as
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baseline. RIFLE based on urine output was scored per
hour, where 6, 12 or 24 hour stretches of oliguria or an-
uria were scored according to the RIFLE classification.
Hours with missing urine output were replaced by div-
iding the first known urine output over the stretch of
missing hours. This was done for missing periods up to
6 hours, including the hour with the known urine output
measurement. Renal replacement therapy was scored based
on parameters indicating a running dialysis and invasive
therapy registration. The highest (i.e., worst) acute RIFLE
class based on serum creatinine or urine output attained
during the first 24 hours of admission was used to classify
eAKI in included subjects. Subjects with renal replace-
ment therapy were scored as “failure” regardless of urine
or serum creatinine. More details on this algorithm can be
found in Additional file 2.
Outcomes
The primary outcome measure was one-year “poor out-
come”. This outcome was defined as a composite of
death or low HRQoL at one year follow up. To study the
contribution to the composite endpoint, one-year sur-
vival, and HRQoL in the one-year survivors were ana-
lyzed as separate secondary outcomes.
HRQoL was measured using the EQ-5D. This ques-
tionnaire consists of five questions each representing
a dimension of HRQoL (mobility, self-care, usual ac-
tivities, pain or discomfort, anxiety or depression).
Patients assigned a score of no, little or many prob-
lems to each of these dimensions. The results were
indexed on a scale between 1 (full health) and 0 (dead)
according to the weighting scheme for the Dutch
population [22].
We defined low HRQoL as an EQ-5D index of 0.4 or
below. Patients who qualified their health state as such
are on par with those with moderate to severe amyo-
trophic lateral sclerosis (mean EQ-5D index 0.56–0.27)
[23], patients suffering from dementia with depression
(mean EQ-5D index 0.37) [24], or patients with a severe
to extreme depressive episode (median EQ-5D index
0.57–0.29) [25].
Additional predictors of outcome
Based on the constituents of most benchmark prediction
models (e.g., APACHE and SAPS) additional predictors
were selected. These were age, gender, pre-ICU hospital
length of stay, admission type (medical/elective surgical/ur-
gent surgical), Charlson Comorbidity Index, the need for
mechanical ventilation, confirmed infection and the APA-
CHE II acute physiology score in the first 24 hours of
admission [26] (excluding the points for creatinine). The
association between eAKI and outcomes was adjusted for
overlapping information on the predictive value of these
eight additional predictors.
Missing data
Missing EQ-5D data were expected to occur in non-
responding one-year survivors. Multiple imputation was
used to replace the missing EQ-5D dimension scores of
non-responding survivors [27–30]. A total of 35 imput-
ation datasets were created. Further details can be found
in Additional file 1.
Data analysis
Baseline-characteristics and outcomes were compared
across RIFLE classes using the Chi2 test for categorical
variables and were compared non-parametrically using
the Kruskal-Wallis test for continuous variables. The as-
sociation between RIFLE and poor outcome was ana-
lysed using multivariable Poisson regression analysis,
modified for binomial outcomes, adjusting for the afore-
mentioned additional risk factors [31]. To adjust for any
non-linearity in the association of continuous variables
with outcome, fractional polynomial transformations
were added to the model [32]. Cox proportional hazard
regression analysis was conducted to assess the association
between eAKI and one-year survival. Any violation of the
proportional hazard assumption was verified and where
necessary adjusted for by including an interaction term
with time in the regression model. In one-year survivors
we investigated the association between eAKI and low
HRQoL by using a similar multivariable modified Poisson
regression analysis as for the primary outcome. Rubin’s
rule for pooling multiple imputation datasets was used to
arrive at correct effect estimates and standard errors [27].
All statistical analyses were two-sided using a level of sig-
nificance of 0.05. Statistical analyses were performed using
IBM SPSS statistics software package version 21 (IBM,
USA, 2012). Fractional polynomial analyses were performed
in R, version 3.2.0 (R Foundation for Statistical Computing,
2015) using the “mfp” package, version 1.5.1 (2015).
Results
Study population
During the inclusion period, 2420 out of 2601 eligible
ICU patients were included in this study. One-year sur-
vival in the entire population was 1549/2420 patients
(64.0 %). Of surviving patients, 1020/1549 (65.8 %) res-
ponded to the EQ-5D questionnaire. Hence the outcome
status of a total of 1891/2420 (78.0 %) patients one year
after ICU admission was known (either alive with known
HRQoL (n = 1020) or dead (n = 871)) (see Fig. 1).
In the total study population, the median age was
59 years (interquartile range (IQR) 47–69) and 1000/
2420 patients (41.3 %) were female. The majority of pa-
tients, 1418/2420 (58.6 %), were admitted for medical
reasons and 1231/2420 patients (50.9 %) had a Charlson
Comorbidity Index of one or higher. The median APA-
CHE II score was 19 (IQR 14–25) (see Table 1).
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Within the first 24 hours of admission 832/2420 pa-
tients fulfilled the RIFLE criteria for risk (456/2420;
18.8 %), injury (253/2420; 10.4 %) or failure (123/2420;
5.1 %). Out of the 123 patients classified as eAKI fail-
ure, 62 had renal replacement therapy initiated on the
first day of admission. The median time from ICU ad-
mission to renal replacement therapy was 7 hours (IQR
4.4–14.5). Except for gender and mechanical ventilation
within the first 24 hours of admission, distribution
across RIFLE classes differed significantly for all base-
line characteristics, with older age, frequent comorbidi-
ties and greater disease severity in the RIFLE injury and
failure groups (see Table 1).
Outcomes
Table 2 shows the numbers of patients with one-year poor
outcome, mortality, and in one-year survivors, HRQoL.
Poor outcome was seen in 1157/2420 subjects (47.8 %) in
the total population. In the eAKI subgroups of no eAKI,
risk, injury and failure, the incidence of one-year poor
outcome was 43.7 % (694/1588), 49.1 % (224/456), 59.7 %
(151/253) and 72.4 % (89/123), respectively. Survival rates
differed significantly between patients with no AKI and
those with increasing severity of eAKI.
When compared to the patients who did not experi-
ence eAKI, the unadjusted relative risk (RR) for poor
outcome was 1.12 (95 % CI 0.99, 1.26; p = 0.05) for RI-
FLE class, risk, 1.36 (95 % CI 1.20, 1.55; p < 0.001) for in-
jury and 1.64 (95 % CI 1.34, 2.02; p <0.001) for failure.
After adjustment for the aforementioned additional set
of predictors, the association with poor outcome of RI-
FLE classes, injury (RR 1.14; 95 % CI 1.01, 1.29; p = 0.03)
and failure (RR 1.25; 95 % CI 1.01, 1.55; p = 0.04) remained
statistically significant (see Table 3). Additional file 3 con-
tains separate analyses of the association between eAKI
and poor outcome in previously defined ICU subgroups
[16]. The association of eAKI with outcome did not differ
across subgroups based on admission diagnoses or num-
ber of comorbidities. No clear association was seen be-
tween eAKI and poor outcome only in patients admitted
with traumatic brain injury. eAKI was most frequent in
ICU patients with sepsis: 21.6 % of the group of 449
patients (n = 97) experienced eAKI risk, 14.3 % (n = 64)
experienced eAKI injury and 12.0 % experienced eAKI
failure (n = 54).
In the Cox regression analysis, crude estimates of the
hazard ratios for mortality in the eAKI RIFLE classes were
1.23 (95 % CI 1.03, 1.46; p = 0.02), 1.67 (95 % CI 1.37, 2.04;
p < 0.001) and 2.45 (95 % CI 1.92, 3.13; p < 0.001) for risk,
injury and failure. After adjustment for the additional pre-
dictors, the hazard ratios for RIFLE classes, injury and fail-
ure, remained statistically significant: 1.35 (95 % CI 1.10,
1.65; p = 0.004) and 1.77 (95 % CI 1.37, 2.28; p < 0.001)
(see Table 3). In one-year survivors none of the RIFLE
classes were independently associated with low HRQoL
(see Table 3).
Discussion
This cohort study showed that occurrence of AKI early
during the ICU stay was associated with an increased
probability of being dead or having low HRQoL one year
after ICU admission. When compared to patients without
eAKI, patients with increasing eAKI severity were associ-
ated with increasing risks of poor outcome one year after
the ICU stay. Patients with a RIFLE class, failure, on
the first day of admission even had a 25 % signifi-
cantly increased risk of poor outcome, independent of
other measured predictors.
To illustrate the effect of eAKI in the setting of the high
overall outcome incidence, we used our full statistical
model to calculate the absolute predicted probability of
N = 4,077 unique non cardiac 
surgery patients without 
chronic dialysis admitted to  
the ICU from July 2009 to 
April 2013
N = 2,601/4,077 unique ICU 
patients eligible
N = 411/2,420 (17.0%)
patients died on ICU
N = 181/2,420 (7.5%)
patients died in hospital
N = 279/2,420 (11.5%)
patients died after discharge 
within first year of follow-up
In total N = 871/2,420 
(36.0%) patients died within 
first year of follow-up
N = 1,549/2,420 (64.0%)
survivors, which were sent a  
survey
N = 529/1,549 (34.2%) 
survivors did not return a  
(completed) survey 
N = 1,020/1,549 (65.8%)
survivors sent a survey 
returned a completed survey 
Excluded: N = 1,476/4,077 
(36.2%) patients with an ICU 
length of stay <24 hours 
Lost to follow up:
N = 181/4,077 (4.4%) 
patients had a missing 
address in the municipal 
registry (n=109), did not  
want to participate (n=52) or 
survival status was unknown 
(n=20)Included: N = 2,420/4,077
unique ICU patients
Fig. 1 Flowchart. ICU intensive care unit
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poor outcome for two typical ICU patients. Patient A is a
low-risk 40-year-old male patient, without comorbidities,
admitted to the ICU after elective surgery and a day of
prior hospital stay, without an infection or mechanical
ventilation within 24 hours of ICU admission and an
Acute Physiology Score (APS) of 10. Patient B is a high-
risk 60-year-old female patient, with a Charlson Comor-
bidity Index of 3, admitted to the ICU for medical reasons
after a week of prior hospital stay, with a confirmed infec-
tion and mechanical ventilation within 24 hours of ICU
admission and an APS of 20. If these patients developed
severe eAKI (RIFLE failure) Patient A’s risk of poor out-
come would increase from 21 to 26 %, while Patient B’s
risk would rise from 58 to 72 % (see Table 4 for the full
statistical model).
Patients, family members and clinicians desire more
prognostic information about an ICU patient’s survival in
conjunction with the expected HRQoL than is currently
available [2, 33, 34]. Furthermore, long-term quality of life
is conditional on long-term survival. When patients base
decisions made during the ICU stay on predicted HRQoL,
they need information which also takes into account the
condition of long-term survival. We decided to tackle this
form of conditionality by creating a composite outcome
that is clinically relevant at the time of major ICU treat-
ment decisions. To our knowledge, this is the first study
Table 1 Patient characteristics in the total population and by RIFLE class
Total
population
RIFLE class P value
No AKI Risk Injury Failure
Number 2420 1588 (65.6 %) 456 (18.8 %) 253 (10.5 %) 123 (5.1 %)
Gender (female) 1000 (41.3 %) 662 (41.7 %) 196 (43 %) 97 (38.3 %) 45 (36.6 %) .446
Age (years) 59 (47–69) 58 (45–67) 60.5 (50–71) 63 (53–74) 61 (50–72) <.001
ICU length of stay (days) 3.8 (2–8) 3.4 (2–7) 4.8 (2–9) 4.7 (2–10) 5.3 (2–12) <.001
Hospital length of stay (days) 17 (8–31) 16.2 (8–29) 18.2 (10–32) 19.9 (8–38) 23.5 (9–40) .004
Pre-ICU length of stay (days) 0.2 (0–1) 0.2 (0–1) 0.2 (0–1) 0.4 (0–3) 0.4 (0–6) <.001
Admission type <.001
Elective surgical 330 (13.6 %) 244 (15.4 %) 47 (10.3 %) 33 (13 %) 6 (4.9 %)
Urgent surgical 672 (27.8 %) 460 (29 %) 134 (29.4 %) 59 (23.3 %) 19 (15.4 %)
Medical 1418 (58.6 %) 884 (55.7 %) 275 (60.3 %) 161 (63.6 %) 98 (79.7 %)
Pre-ICU health state
Charlson Comorbidity Index 1 (0–2) 0 (0–2) 1 (0–2) 2 (0–4) 2 (0–6) <0.001
Chronic cardiac insufficiency 217 (9 %) 118 (7.4 %) 50 (11 %) 32 (12.6 %) 17 (13.8 %) 0.003
Chronic respiratory insufficiency or COPD 394 (16.3 %) 229 (14.4 %) 95 (20.8 %) 55 (21.7 %) 15 (12.2 %) <0.001
Chronic renal insufficiency 96 (4 %) 34 (2.1 %) 12 (2.6 %) 16 (6.3 %) 34 (27.6 %) <0.001
Mild or severe liver disease 45 (1.9 %) 19 (1.2 %) 7 (1.5 %) 10 (4 %) 9 (7.3 %) <0.001
Metastatic malignancy 96 (4 %) 53 (3.3 %) 18 (3.9 %) 14 (5.5 %) 11 (8.9 %) 0.016
Haematological malignancy 112 (4.6 %) 54 (3.4 %) 21 (4.6 %) 19 (7.5 %) 18 (14.6 %) <0.001
HIV positivity, AIDS, or other immunodeficiency 284 (11.7 %) 151 (9.5 %) 56 (12.3 %) 45 (17.8 %) 32 (26 %) <0.001
Diabetes 341 (14.1 %) 168 (10.6 %) 95 (20.8 %) 54 (21.3 %) 24 (19.5 %) <0.001
Body mass index 24.7 (22–28) 24.2 (22–27) 25.7 (23–29) 26.1 (23–30) 26 (22–29) <0.001
Severity of disease markers
Mechanical ventilation within first 24 hours of ICU stay 2188 (90.4 %) 1426 (89.8 %) 424 (93 %) 230 (90.9 %) 108 (87.8 %) 0.157
Confirmed infection in the first 24 hours of ICU admission 651 (26.9 %) 337 (21.2 %) 136 (29.8 %) 102 (40.3 %) 76 (61.8 %) <0.001
APACHE II Acute Physiology Score (without creatinine) 17 (13–23) 17 (13–22) 17 (14–23) 17 (14–24) 20 (15–26) <0.001
APACHE II score (unmodified) 19 (14–25) 18 (14–24) 20 (15–26) 22 (17–28) 29 (23–34) <0.001
Total maximum SOFA score (sum of highest SOFA
component scores)
9 (6–12) 8 (5–11) 10 (7–13) 12 (8–16) 16 (12–18) <0.001
SOFA score on day of discharge 5 (3–7) 4 (3–6) 5 (3–7) 6 (3–9) 7 (5–13) <0.001
Values are expressed as number (percentage) for categorical variables and as median (interquartile range) for continuous variables. RIFLE risk, injury, failure, loss,
end-stage renal failure, AKI acute kidney injury, ICU intensive care unit; COPD chronic obstructive pulmonary disease, HIV human immunodeficiency virus, AIDS
acquired immune deficiency syndrome, APACHE IV acute physiology and chronic health evaluation version IV, SOFA sequential organ failure assessment
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to specifically address this clinically relevant composite
endpoint of poor outcome.
So, in respect to the results of previous studies, only the
result on the separate constituents of this composite out-
come can be compared. The association between (e)AKI
and mortality described here is supported by current
literature. A recent systematic review described studies of
survival for 6 months after ICU discharge. The included
studies all reported a large and significant decrease in sur-
vival probability in the AKI failure group when compared
to all other AKI or no AKI groups [35]. Three studies have
reported on the association between (e)AKI and HRQoL
in long-term ICU survivors and support the findings
presented here. When comparing those survivors who
had suffered from (e)AKI and survivors without (e)AKI,
there was no significant association with any HRQoL
classification [12, 36, 37]. Based on another recent sys-
tematic review, the presented study population is by far
the largest one to date [38]. Additionally, none of the
prior AKI and HRQoL studies took into account the
conditionality of HRQoL on survival [12, 36–38]. Fi-
nally, with respect to the contribution of survival and
HRQoL to the composite endpoint, the increased risk
of eAKI for poor outcome seemed to be mainly caused
by an increased risk of death within one year after ICU
admission.
Different from these previous studies, HRQoL was
analysed dichotomously in this study. Aside from this
being necessary in order to determine whether a patient
suffered from a poor composite outcome, a qualitative
interpretation of HRQoL (“low” versus “high” or “severely
impaired HRQoL” vs. “not or mildly impaired HRQoL”)
was constructed. Choosing a threshold was, and still is,
not straightforward. The EQ-5D index itself contained
minimal qualitative interpretation: its guidelines merely
indicated that a score of 1 corresponds to “full health” and
scores below zero to equal states of living valued worse
than death [22]. We therefore decided to set a threshold
value based on the average EQ-5D index value measured
in patients with severe physical, cognitive and/or psychi-
atric disabilities [23–25]. Still, after classifying patients as
such, patients with a low HRQoL might not have consid-
ered themselves to be (severely) disabled. However, based
on the EQ-5D index formula it can be shown that patients
with an EQ-5D index below 0.4 all experienced extreme
problems on at least one of the EQ-5D dimensions [22].
Altogether we assumed this threshold therefore corre-
sponded to a clinically relevant major disability or impair-
ment of HRQoL one year after ICU admission.
A strong feature of this study is that we measured
and defined RIFLE classification in high detail using
an algorithm for routinely collected data. In this study, as
originally proposed by Bellomo et al., the RIFLE classifica-
tion was based on both serum creatinine changes and
urine output per hour [5]. As a result, this study distin-
guished itself from those studies using only serum creatin-
ine changes and/or 24 hour urine output when classifying
AKI [35, 39].
Another strength of this study is the way attrition was
handled. In cohort studies with lengthy follow up non-
response occurs frequently, but seldom completely at
random. Consequently, not properly dealing with non-
response may lead to bias in any direction by selective
loss to follow up [27–30]. In order to minimize the risk
of this bias, multiple imputation techniques were used.
Additionally, the internal structure of the EQ-5D index
Table 2 Crude outcomes
Total population RIFLE class P value
No eAKI Risk Injury Failure
Number at study inclusion 2420 1588 456 253 123
Composite outcome
Poor outcome 1157/2420 (47.8 %) 694/1588 (43.7 %) 224/456 (49.1 %) 151/253 (59.7 %) 89/123 (72.4 %) <0.001
Mortalitya
ICU mortality 411 (17 %) 215 (13.5 %) 90 (19.7 %) 65 (25.7 %) 41 (33.3 %) <0.001
Hospital mortality 592 (24.5 %) 334 (21 %) 117 (25.7 %) 86 (34 %) 55 (44.7 %) <0.001
One-year mortality 871 (36 %) 503 (31.7 %) 172 (37.7 %) 122 (48.2 %) 74 (60.2 %) <0.001
Health-related quality of life in one-year survivors
EQ-5D response 1020/1549 (65.8 %) 735/1085 (67.7 %) 181/284 (63.7 %) 76/131 (58 %) 28/49 (57.1 %) 0.057
EQ-5D index score 0.806 (0.59-0.94) 0.81 (0.64-1.00) 0.778 (0.57-0.89) 0.772 (0.47-0.87) 0.666 (0.37-0.85) 0.076
Low HRQoLb 286/1549 (18.5 %) 191/1085 (17.6 %) 52/284 (18.3 %) 29/131 (22.1 %) 15/49 (30.6 %) 0.927
Values are expressed as number (percentage) for categorical variables and as median (interquartile range) for continuous variables. Results were pooled from 35
imputation datasets, using Rubin’s rule to pool statistical test results. aNumbers for ICU, hospital and one-year mortality are cumulative; bLow health related quality
of life (HRQoL) was defined as a EuroQoL 5D-3L™ questionnaire (EQ-5D) index below 0.4. RIFLE risk, injury, failure, loss, end-stage renal failure, eAKI early acute
kidney injury, ICU intensive care unit
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was maintained by using these techniques to replace the
missing EQ-5D dimensions in survivors who did not
respond to the EQ-5D questionnaire, instead of the
EQ-5D index value.
However, potential limitations also have to be ac-
knowledged. One limitation of this study is potential un-
measured relevant predictors of poor outcome, and
effect modification. In particular, frailty before ICU ad-
mission [40] and cardiac or respiratory complications
during early ICU admission [41] have recently been sug-
gested as being closely related to, and possibly reducing
or altering, the association between AKI and long-term
outcomes. As we did not collect data on these variables,
it was not possible to account for these factors in our
analyses. We did study the predictive values of eAKI in
different subgroups (see Additional file 3). These ana-
lyses suggested no effect modification or only slight ef-
fect modification. Future prognostic studies could study
this phenomenon in more detail by accounting for effect
modification and frailty in their models.
Another limitation, is that these results apply to the
first day of admission only. This might have resulted in
an attenuated estimate. The estimate of the effect of
eAKI could have been decreased due to patients without
early AKI then experiencing AKI later during admission.
Data to verify or reject these shortcomings were not
available at this time, and this was not the goal of this
study. Future research will be aimed at predictors of out-
come during the later days of ICU admission.
In clinical practice, some patients and doctors will base
their decision for treatment continuation on survival pre-
dictions alone, while others decide to incorporate the ex-
pected quality of life as the main argument for their
treatment wishes. In the process of shared decision-
making and accurately informing patients and families,
clinicians will then want to provide relevant information
[1, 2], without relying on a single predictor for a single
outcome. So, given its strong independent association
with survival and the composite, poor outcome, which in-
corporates HRQoL, the severity of eAKI should be consid-
ered as a candidate predictor in the future development of
multivariable and personalized decision support models,
to be used during ICU admission.
Conclusions
The severity of AKI early during ICU admission was inde-
pendently associated with increasing risk of one-year poor
outcome. In particular, patients with severe eAKI (RIFLE
class failure) had a substantially increased risk of poor out-
come one year after ICU admission. Together with other
early available prognostic factors, information on early
acute kidney injury could improve risk-stratification and
hence informed decision-making on the continuation or
withdrawal of treatment in ICU patients.
Table 3 Association eAKI and long-term outcomes
Results were pooled from 35 imputation datasets, using Rubin’s rule. aAdjusted for
age, gender, Charlson Comorbidity Index, pre-ICU admission hospital length of stay,
admission type, acute physiology score (without creatinine), mechanical ventilation
in the first 24 hours of admission and confirmed infection in the first 24 hours of
admission. bLow HRQoL was defined as a EuroQoL 5D-3L™ questionnaire (EQ-5D)
index below 0.4; age was transformed into ((age-16)/100)^2, APS was transformed
into ((APS-1)/10)^-1 + ((APS-1)/10). APS Acute Physiology Score, RIFLE risk, injury, fail-
ure, loss, end-stage renal failure, eAKI early acute kidney injury; ICU intensive care
unit, HRQoL health-related quality of life
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condensed guide on how to replicate our AKI algorithm. Additionally, the
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the subgroup analyses for the association of eAKI and poor outcome.
(DOCX 32 kb)
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eAKI No eAKI Reference
Risk 0.023 1.02 0.91, 1.15 0.691
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